Into the Eye of the Cytokine Storm

SUMMARY The cytokine storm has captured the attention of the public and the scientific community alike, and while the general notion of an excessive or uncontrolled release of proinflammatory cytokines is well known, the concept of a cytokine storm and the biological consequences of cytokine overproduction are not clearly defined. Cytokine storms are associated with a wide variety of infectious and noninfectious diseases. The term was popularized largely in the context of avian H5N1 influenza virus infection, bringing the term into popular media. In this review, we focus on the cytokine storm in the context of virus infection, and we highlight how high-throughput genomic methods are revealing the importance of the kinetics of cytokine gene expression and the remarkable degree of redundancy and overlap in cytokine signaling. We also address evidence for and against the role of the cytokine storm in the pathology of clinical and infectious disease and discuss why it has been so difficult to use knowledge of the cytokine storm and immunomodulatory therapies to improve the clinical outcomes for patients with severe acute infections.

[1]  J. Farrar,et al.  Insights into inflammation and influenza. , 2008, The New England journal of medicine.

[2]  D. Zeldin,et al.  Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice , 2010, PloS one.

[3]  A. Attaran,et al.  Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study , 2008, PloS one.

[4]  P. Holt,et al.  Regulation of immunological homeostasis in the respiratory tract , 2008, Nature Reviews Immunology.

[5]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[6]  N. Voirin,et al.  Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock , 2006, Intensive Care Medicine.

[7]  P. Österlund,et al.  Pandemic H1N1 2009 Influenza A Virus Induces Weak Cytokine Responses in Human Macrophages and Dendritic Cells and Is Highly Sensitive to the Antiviral Actions of Interferons , 2009, Journal of Virology.

[8]  J. Ferrara,et al.  Cytokine dysregulation as a mechanism of graft versus host disease. , 1993, Current opinion in immunology.

[9]  I. Clark How TNF was recognized as a key mechanism of disease. , 2007, Cytokine & growth factor reviews.

[10]  R. Friedman Clinical uses of interferons. , 2008, British journal of clinical pharmacology.

[11]  Arthur S Slutsky,et al.  Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury , 2008, Cell.

[12]  G. Janossy,et al.  Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited , 2000, Bone Marrow Transplantation.

[13]  Lei Sun,et al.  New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[14]  R. Danner,et al.  Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. , 1993, The New England journal of medicine.

[15]  E. Ramsburg,et al.  CCR2-Antagonist Prophylaxis Reduces Pulmonary Immune Pathology and Markedly Improves Survival during Influenza Infection , 2011, The Journal of Immunology.

[16]  P. Suter,et al.  Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. , 1996, American journal of respiratory and critical care medicine.

[17]  Osamu Takeuchi,et al.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction , 2005, Nature Immunology.

[18]  B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[19]  I. Clark,et al.  Increased Survival after Gemfibrozil Treatment of Severe Mouse Influenza , 2007, Antimicrobial Agents and Chemotherapy.

[20]  S. Imashuku Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. , 2002, Critical reviews in oncology/hematology.

[21]  A. Kingsnorth,et al.  Cytokine storm in acute pancreatitis. , 2002, Journal of hepato-biliary-pancreatic surgery.

[22]  Houli Wang,et al.  The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. , 2008, The American journal of emergency medicine.

[23]  J. Farrar,et al.  Pretreatment Intracerebral and Peripheral Blood Immune Responses in Vietnamese Adults with Tuberculous Meningitis: Diagnostic Value and Relationship to Disease Severity and Outcome , 2006, The Journal of Immunology.

[24]  S. Akira,et al.  Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.

[25]  E. Cordero,et al.  Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia. , 2011, The Journal of infection.

[26]  Hung-Yi Wu,et al.  Upregulation of the Chemokine (C-C Motif) Ligand 2 via a Severe Acute Respiratory Syndrome Coronavirus Spike-ACE2 Signaling Pathway , 2010, Journal of Virology.

[27]  R. Centor,et al.  Development of the adult respiratory distress syndrome: progressive alteration of neutrophil chemotactic and secretory processes. , 1984, The American journal of pathology.

[28]  S. McColl,et al.  Mini‐review series: focus on chemokines , 2011, Immunology and cell biology.

[29]  A. Luster,et al.  CXCR3 ligands: redundant, collaborative and antagonistic functions , 2011, Immunology and cell biology.

[30]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[31]  Osamu Takeuchi,et al.  Cell type-specific involvement of RIG-I in antiviral response. , 2005, Immunity.

[32]  R. Webster,et al.  H5N1 Influenza Virus Pathogenesis in Genetically Diverse Mice Is Mediated at the Level of Viral Load , 2011, mBio.

[33]  Kaoru Tominaga,et al.  Activation of innate immune antiviral response by NOD2 , 2009, Nature Immunology.

[34]  M. Wurfel Genetic insights into sepsis: what have we learned and how will it help? , 2008, Current pharmaceutical design.

[35]  J. Farrar,et al.  Timing of CD8+ T Cell Responses in Relation to Commencement of Capillary Leakage in Children with Dengue , 2010, The Journal of Immunology.

[36]  T. Tumpey,et al.  Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice , 2006, Journal of Virology.

[37]  C. Brocker,et al.  Evolutionary divergence and functions of the human interleukin (IL) gene family , 2010, Human Genomics.

[38]  I. Humphreys,et al.  TGF-beta prevents eosinophilic lung disease but impairs pathogen clearance. , 2005, Microbes and infection.

[39]  R. Proia,et al.  The alliance of sphingosine-1-phosphate and its receptors in immunity , 2008, Nature Reviews Immunology.

[40]  Ann Richmond,et al.  Chemokines in health and disease. , 2011, Experimental cell research.

[41]  David E. Swayne,et al.  Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus , 2006, Nature.

[42]  S. Kalayanarooj,et al.  Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever , 2006, Journal of Virology.

[43]  Carole R. Baskin,et al.  Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus , 2009, Proceedings of the National Academy of Sciences.

[44]  K. Asadullah,et al.  Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. , 1997, Nature medicine.

[45]  R. Albrecht,et al.  Experimental Infection of Pigs with the Human 1918 Pandemic Influenza Virus , 2009, Journal of Virology.

[46]  S. Yokota [Influenza-associated encephalopathy--pathophysiology and disease mechanisms]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.

[47]  D. Golenbock,et al.  Malaria primes the innate immune response due to interferon-γ induced enhancement of toll-like receptor expression and function , 2009, Proceedings of the National Academy of Sciences.

[48]  Clark,et al.  Possible importance of macrophage-derived mediators in acute malaria , 1981, Infection and immunity.

[49]  H. Bruining,et al.  p55 Tumor Necrosis Factor Receptor Fusion Protein in the Treatment of Patients With Severe Sepsis and Septic Shock: A Randomized Controlled Multicenter Trial , 1997 .

[50]  Chengjun Li,et al.  Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems , 2011, BMC Systems Biology.

[51]  Lucy A. Perrone,et al.  Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. , 2010, The Journal of infectious diseases.

[52]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[53]  J. Pugin,et al.  Cytokine balance in the lungs of patients with acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.

[54]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[55]  R. Schumann,et al.  Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. , 2006, The Journal of infectious diseases.

[56]  Yi Guan,et al.  Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro , 2010, Respiratory research.

[57]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[58]  J. Alcorn,et al.  Critical Role of IL-17RA in Immunopathology of Influenza Infection , 2009, The Journal of Immunology.

[59]  A. Garin,et al.  Chemokines as targets for therapy. , 2011, Experimental cell research.

[60]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[61]  J. Renauld,et al.  Interferon-λ Contributes to Innate Immunity of Mice against Influenza A Virus but Not against Hepatotropic Viruses , 2008, PLoS pathogens.

[62]  T. Hussell,et al.  Structured regulation of inflammation during respiratory viral infection. , 2010, The Lancet. Infectious diseases.

[63]  L. Hung,et al.  Antiarrhythmic Effect of Magnolol and Honokiol during Acute Phase of Coronary Occlusion in Anesthetized Rats: Influence of L-NAME and Aspirin , 1999, Pharmacology.

[64]  Michael G. Katze,et al.  Distinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity , 2007, Journal of Virology.

[65]  A. Bisno,et al.  Molecular basis of group A streptococcal virulence. , 2003, The Lancet. Infectious diseases.

[66]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[67]  I. Humphreys,et al.  A Critical Role for OX40 in T Cell–mediated Immunopathology during Lung Viral Infection , 2003, The Journal of experimental medicine.

[68]  Jean H. Chang,et al.  Host Regulatory Network Response to Infection with Highly Pathogenic H5N1 Avian Influenza Virus , 2011, Journal of Virology.

[69]  T. Martin,et al.  Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. , 1999, The Journal of clinical investigation.

[70]  M. Bachmann,et al.  Averting inflammation by targeting the cytokine environment , 2010, Nature Reviews Drug Discovery.

[71]  Nicki Panoskaltsis,et al.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. , 2006, The New England journal of medicine.

[72]  T. Sawa,et al.  Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU* , 2004, Critical care medicine.

[73]  Yoshihiro Kawaoka,et al.  A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection , 2009, Proceedings of the National Academy of Sciences.

[74]  Michael G. Katze,et al.  Innate immune modulation by RNA viruses: emerging insights from functional genomics , 2008, Nature Reviews Immunology.

[75]  W. Junger,et al.  Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury , 2009, Nature.

[76]  R. Beyaert,et al.  A20: Central Gatekeeper in Inflammation and Immunity* , 2009, Journal of Biological Chemistry.

[77]  Jonathan Cohen The immunopathogenesis of sepsis , 2002, Nature.

[78]  D. J. Arora,et al.  Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase. , 1990, Cellular immunology.

[79]  E. Ramsburg,et al.  CCR2+ Monocyte-Derived Dendritic Cells and Exudate Macrophages Produce Influenza-Induced Pulmonary Immune Pathology and Mortality1 , 2008, The Journal of Immunology.

[80]  Lei Zhu,et al.  ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury , 1997, Molecular microbiology.

[81]  T. Akazawa,et al.  TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction , 2003, Nature Immunology.

[82]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[83]  R. Schumann,et al.  Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. , 2006, The Journal of communicable diseases.

[84]  M. Neumann,et al.  Peroxisome proliferator‐activated receptor‐γ agonists inhibit respiratory syncytial virus‐induced expression of intercellular adhesion molecule‐1 in human lung epithelial cells , 2007 .

[85]  H. Yen,et al.  Host response to influenza virus: protection versus immunopathology. , 2010, Current opinion in immunology.

[86]  M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.

[87]  Ralph S. Baric,et al.  SARS-CoV Pathogenesis Is Regulated by a STAT1 Dependent but a Type I, II and III Interferon Receptor Independent Mechanism , 2010, PLoS pathogens.

[88]  G. Dougan,et al.  OX40 Ligation on Activated T Cells Enhances the Control of Cryptococcus neoformans and Reduces Pulmonary Eosinophilia , 2003, The Journal of Immunology.

[89]  H. Link The cytokine storm in multiple sclerosis , 1998, Multiple sclerosis.

[90]  P. Doherty,et al.  A question of self‐preservation: immunopathology in influenza virus infection , 2007, Immunology and cell biology.

[91]  A. Rothman,et al.  Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo , 2009, Journal of medical virology.

[92]  Samson S. Y. Wong,et al.  Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus , 2008, Proceedings of the National Academy of Sciences.

[93]  A. Nisalak,et al.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. , 2002, The Journal of infectious diseases.

[94]  Ali Danesh,et al.  Interferon-Mediated Immunopathological Events Are Associated with Atypical Innate and Adaptive Immune Responses in Patients with Severe Acute Respiratory Syndrome , 2007, Journal of Virology.

[95]  Yan Li,et al.  Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus , 2007, Nature.

[96]  R. Webster,et al.  Tumor Necrosis Factor Alpha Exerts Powerful Anti-Influenza Virus Effects in Lung Epithelial Cells , 2002, Journal of Virology.

[97]  M. Katze,et al.  Pandemic Swine-Origin H1N1 Influenza A Virus Isolates Show Heterogeneous Virulence in Macaques , 2010, Journal of Virology.

[98]  Scott R. Presnell,et al.  IL-28, IL-29 and their class II cytokine receptor IL-28R , 2002, Nature Immunology.

[99]  D. Gemsa,et al.  Influenza A virus infects macrophages and stimulates release of tumor necrosis factor-alpha. , 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

[100]  A. Barclay,et al.  A critical function for CD200 in lung immune homeostasis and the severity of influenza infection , 2008, Nature Immunology.

[101]  Graham R. Foster,et al.  Interferons at age 50: past, current and future impact on biomedicine , 2007, Nature Reviews Drug Discovery.

[102]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[103]  P. Openshaw,et al.  Inhibition of tumor necrosis factor reduces the severity of virus‐specific lung immunopathology , 2001, European journal of immunology.

[104]  I. Humphreys,et al.  TGF-β prevents eosinophilic lung disease but impairs pathogen clearance , 2005 .

[105]  T. Martin,et al.  Animal models of acute lung injury , 2008, American journal of physiology. Lung cellular and molecular physiology.

[106]  Peter Tontonoz,et al.  Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.

[107]  Diane P. Martin,et al.  Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.

[108]  Xinxia Peng,et al.  Lethal Influenza Virus Infection in Macaques Is Associated with Early Dysregulation of Inflammatory Related Genes , 2009, PLoS pathogens.

[109]  A. Murphy,et al.  Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung , 2011, Proceedings of the National Academy of Sciences.

[110]  L. Chess,et al.  Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.

[111]  T. van der Poll,et al.  Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia. , 2007, Clinical immunology.

[112]  P. Sly,et al.  TLR4 Polymorphisms Mediate Impaired Responses to Respiratory Syncytial Virus and Lipopolysaccharide1 , 2007, The Journal of Immunology.

[113]  L. Joosten,et al.  IL-1 family nomenclature , 2010, Nature Immunology.

[114]  J. Farrar,et al.  Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. , 2007, The Journal of infectious diseases.

[115]  M. Rieder,et al.  Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. , 2008, American journal of respiratory and critical care medicine.

[116]  Jacques Fellay,et al.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.

[117]  Yoshihiro Kawaoka,et al.  Avian flu: Influenza virus receptors in the human airway , 2006, Nature.

[118]  Y. Guan,et al.  Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation , 2010, Virology.

[119]  J. Pugin,et al.  Normal responses to injury prevent systemic inflammation and can be immunosuppressive. , 2001, American journal of respiratory and critical care medicine.

[120]  W. Bos,et al.  Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial , 2011, The Lancet.

[121]  H. Bruining,et al.  p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. , 1997, JAMA.

[122]  I. Clark,et al.  The advent of the cytokine storm , 2007, Immunology and cell biology.

[123]  G. Sen,et al.  Interferons and viral infections , 2009, BioFactors.

[124]  Robert Peach,et al.  Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection , 2011, Cell.

[125]  Tao Dong,et al.  Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever , 2003, Nature Medicine.

[126]  N. M. Dung,et al.  Patterns of gene transcript abundance in the blood of children with severe or uncomplicated dengue highlight differences in disease evolution and host response to dengue virus infection. , 2009, The Journal of infectious diseases.

[127]  G. Gudmundsson,et al.  Respiratory Syncytial Virus Up-regulates TLR4 and Sensitizes Airway Epithelial Cells to Endotoxin* , 2003, Journal of Biological Chemistry.

[128]  J. Tregoning,et al.  Role of CCL5 (RANTES) in Viral Lung Disease , 2006, Journal of Virology.

[129]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[130]  Y. Guan,et al.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[131]  J. Bassaganya-Riera,et al.  PPAR-gamma activation as an anti-inflammatory therapy for respiratory virus infections. , 2010, Viral immunology.

[132]  Chris T. A. Evelo,et al.  Presenting and exploring biological pathways with PathVisio , 2008, BMC Bioinformatics.

[133]  J. Ferrara,et al.  Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1. , 1993, Transplantation proceedings.

[134]  David E. Swayne,et al.  Genomic Profiling of Tumor Necrosis Factor Alpha (TNF-α) Receptor and Interleukin-1 Receptor Knockout Mice Reveals a Link between TNF-α Signaling and Increased Severity of 1918 Pandemic Influenza Virus Infection , 2010, Journal of Virology.

[135]  M. Katze,et al.  2009 Pandemic H1N1 Influenza Virus Causes Disease and Upregulation of Genes Related to Inflammatory and Immune Responses, Cell Death, and Lipid Metabolism in Pigs , 2011, Journal of Virology.

[136]  Pedro Romero,et al.  Type I interferon inhibits interleukin-1 production and inflammasome activation. , 2011, Immunity.

[137]  Xinxia Peng,et al.  Lethal Dissemination of H5N1 Influenza Virus Is Associated with Dysregulation of Inflammation and Lipoxin Signaling in a Mouse Model of Infection , 2010, Journal of Virology.

[138]  Martin F. Bachmann,et al.  Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection , 2005, Journal of Virology.

[139]  D. Relman,et al.  Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[140]  Dirk E. Smith,et al.  The IL-1 family: regulators of immunity , 2010, Nature Reviews Immunology.

[141]  J. Hamilton Colony-stimulating factors in inflammation and autoimmunity , 2008, Nature Reviews Immunology.

[142]  K. Yuen,et al.  Human infection by avian influenza A H5N1. , 2005, Hong Kong medical journal = Xianggang yi xue za zhi.

[143]  Niall J. Lennon,et al.  The Early Whole-Blood Transcriptional Signature of Dengue Virus and Features Associated with Progression to Dengue Shock Syndrome in Vietnamese Children and Young Adults , 2010, Journal of Virology.

[144]  R. Rylander,et al.  Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. , 2003, The Journal of allergy and clinical immunology.

[145]  Y. Guan,et al.  Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. , 2008, The Journal of infectious diseases.

[146]  Y. Guan,et al.  Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells , 2005, Respiratory research.

[147]  G. Prestwich,et al.  Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.

[148]  Arthur S Slutsky,et al.  Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. , 2003, JAMA.

[149]  L. Brochard,et al.  Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. , 2011, American journal of respiratory and critical care medicine.

[150]  B. Aggarwal,et al.  Targeting TNF for Treatment of Cancer and Autoimmunity. , 2009, Advances in experimental medicine and biology.

[151]  Ivana V. Yang,et al.  Genetic analysis of complex traits in the emerging Collaborative Cross. , 2011, Genome research.

[152]  David M. Tobin,et al.  The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans , 2010, Cell.

[153]  M. Katze,et al.  Transcriptomic Analysis Reveals a Mechanism for a Prefibrotic Phenotype in STAT1 Knockout Mice during Severe Acute Respiratory Syndrome Coronavirus Infection , 2010, Journal of Virology.

[154]  S. Akira,et al.  Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.

[155]  D. Kwiatkowski,et al.  Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. , 1998, The Journal of infectious diseases.

[156]  M. Gale,et al.  Immune signaling by RIG-I-like receptors. , 2011, Immunity.

[157]  J. Peiris,et al.  Innate immune responses to influenza A H5N1: friend or foe? , 2009, Trends in immunology.

[158]  Roger E Bumgarner,et al.  Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity , 2006, The Journal of Immunology.

[159]  S. Kaveri,et al.  CISH and susceptibility to infectious diseases. , 2010, The New England journal of medicine.

[160]  Kim L Kusser,et al.  Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity , 2004, Nature Medicine.

[161]  Natalia Novoselova,et al.  Gene expression changes in the host response between resistant and susceptible inbred mouse strains after influenza A infection. , 2010, Microbes and infection.